Finerenone
- Generic Name
- Finerenone
- Brand Names
- Kerendia
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22N4O3
- CAS Number
- 1050477-31-0
- Unique Ingredient Identifier
- DE2O63YV8R
- Background
Finerenone, or BAY 94-8862, is a mineralocorticoid receptor antagonist indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus. Patients with kidney di...
- Indication
In the US, finerenone is indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus.
...
- Associated Conditions
- Cardiovascular Mortality, Chronic Kidney Disease, Stage 3 (Moderate), End Stage Renal Disease (ESRD), Hospitalizations, Nonfatal Myocardial Infarction, Stage 4 Chronic Kidney Disease, Sustained creatinine renal clearance decreased
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.